Skip to main content

Jocelyn Wiesner's practice focuses on complex product liability and mass tort actions, representing a variety of life sciences clients. She has experience defending major pharmaceutical and medical device companies against individual and coordinated personal injury claims in state and federal court across the entire lifecycle of litigation. Most recently Jocelyn acted as lead defense counsel in a coordinated medical device litigation. She has argued multiple dispositive and discovery motions in state and federal court, defended key company depositions, and developed fact and expert discovery and trial strategies. In addition to her work in mass tort actions, Jocelyn represents health care industry clients in consumer fraud class action litigation, where she obtained a denial of class certification under Rule 23(c)(4).

Jocelyn also regularly counsels multinational companies on potential litigation risks related to current and prospective products, evaluating both litigation trends and related U.S. Food and Drug Administration (FDA) regulatory issues. This work has encompassed both traditional product liability risks as well as novel theories of liability related to potential contaminants. 

Jocelyn maintains an active pro bono practice. She has acted as Special Victim's Counsel in multiple military court martial proceedings, where she was able to obtain special courtroom accommodations for child victims and witnesses. She also represents criminal defendants in D.C. Superior Court, including as lead trial counsel in a five-week jury trial. Jocelyn is currently part of a team challenging the constitutionality of a method of execution, where she will take a leading role at trial.

Experience

  • Hologic in medical device product liability cases and counseling. Jocelyn was recently selected as trial counsel for four federal bellwether cases and a related state court case in coordinated medical device litigation.
  • Cynosure in medical device consumer litigation and counseling, including to take a leading role in discovery and related briefing that secured the denial of class certification under Rule 23(c)(4).
  • Bristol-Myers Squibb and Sanofi as counsel in the Plavix product liability litigation and multiple state deceptive practices claims.
  • Sanofi as counsel in the Zantac product liability litigation. 
  • Multinational consumer product companies, as counsel to advise on litigation risks related to talc and PFAS.
  • Fortune 500 company, as lead associate on small trial team. Represented company in breach of contract case in the Eastern District of Virginia.
  • Large manufacturer, as counsel, in investigating whistleblower allegations of corrupt payments in operations in India. Represented company in voluntary disclosures to the U.S. Securities and Exchange Commission and the U.S. Department of Justice. Facilitated global compliance review of operations in other locations in Asia.

Recognition

Best Lawyers
"Ones to Watch" Product Liability Litigation: Defendants (Washington, D.C.) (2023-2025)
"Ones to Watch" Personal Injury Litigation: Defendants (Washington, D.C.) (2023-2025)
"Ones to Watch" Mass Tort Litigation / Class Actions: Defendants (Washington, D.C.) (2023-2025)
The Legal 500 US
Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices — Defense (2022)

Credentials

Education

  • J.D., The George Washington University Law School, 2012, highest honors
  • B.A., Sociology, Providence College, 2007
  • B.S., Biology, Providence College, 2007

Admissions

  • District of Columbia
  • New York
  • U.S. District Court, District of Columbia
  • U.S. District Court, Eastern District of Michigan
  • U.S. Court of Appeals for the Fourth Circuit
Overview